Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Hedlund, Ludwig
DOB: 02-MAR-1950 (Age: 75)
Gender: male
Address:
Djursbo 24
820 64 Näsviken (Sweden)
ID: 1380-437420-8
Report
Date: 13-NOV-2022
Laboratory
Requested by
Hudiksvalls sjukhus
Kungsgatan 33
824 30 Hudiksvall (Sweden)
Specimen
Collected: 12-NOV-2022

Hematology

Test 12 Nov 2022 Reference Range Unit
Leukocytes [#/volume] in Blood by Automated count 3.6 3.5 - 10.5 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 4.2 L 4.5 - 5.7 10*6/uL
Hemoglobin [Mass/volume] in Blood 12.4 L 13.5 - 17.5 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 43.2 37 - 52 %
MCV [Entitic volume] by Automated count 87.3 76 - 98 fL
MCH [Entitic mass] by Automated count 32.3 27 - 35 pg
MCHC [Mass/volume] by Automated count 31.7 31 - 35 g/dL
Erythrocyte distribution width [Ratio] by Automated count 13.6 11.6 - 16.5 %
Platelets [#/volume] in Blood by Automated count 139.6 L 150 - 350 10*3/uL

Chemistry

Test 12 Nov 2022 Reference Range Unit
Glucose [Mass/volume] in Serum or Plasma 80.3 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 8.3 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 3.0 H 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Serum or Plasma 9.1 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Serum or Plasma 138.9 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 4.2 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Serum or Plasma 106.1 H 98 - 106 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 27.3 24 - 29 mmol/L
Protein [Mass/volume] in Serum or Plasma 7.7 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.1 3.2 - 5.5 g/dL
Bilirubin.total [Mass/volume] in Serum or Plasma 14.9 H 0.3 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 66.0 39 - 130 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 27.7 10 - 63 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 25.7 10 - 40 U/L
Magnesium [Mass/volume] in Blood 2.1 1.7 - 2.5 mg/dL
Cholesterol [Mass/volume] in Serum or Plasma 238.8 L 239 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 278.0 H 50 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 134.9 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 22.7 L 40 - 60 mg/dL
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.5 - 6.4 %
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Blood by Immunoassay 1.8 0 - 100 pg/mL
Troponin I.cardiac [Mass/volume] in Serum or Plasma by High sensitivity method 43.7 H 0 - 34.2 ng/L

Coagulation

Test 12 Nov 2022 Reference Range Unit
INR in Platelet poor plasma by Coagulation assay 1.1 0.9 - 2 {INR}
aPTT in Blood by Coagulation assay 33.5 25 - 39 s

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mild normocytic anemia, thrombocytopenia, and significantly impaired renal function (elevated creatinine). There is marked hyperbilirubinemia with normal liver enzymes, suggesting possible hemolysis or cholestasis. Lipid profile is atherogenic (high LDL, triglycerides, low HDL). Cardiac marker (troponin I) is elevated, indicating possible myocardial injury. Further clinical correlation and urgent evaluation for cardiac and renal causes are recommended.